Insider Transactions in Q2 2024 at Ab Cellera Biologics Inc. (ABCL)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2024
|
Veronique Lecault Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
83,334
+3.78%
|
$0
$0.19 P/Share
|
|
May 31
2024
|
Carl L. G. Hansen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,125
+6.67%
|
$112,250
$2.7 P/Share
|